Oropouche virus: Difference between revisions
No edit summary |
Ollama: improve existing draft article |
||
| Line 1: | Line 1: | ||
[[Oropouche virus]] is a zoonotic virus that causes a febrile illness known as Oropouche fever. First identified in 1955 in the Oropouche region of Brazil, the virus belongs to the *Bunyaviridae* family and is primarily transmitted to humans through the bite of infected sandflies (*Psychodidae* family). While initially considered a tropical disease confined to South America, recent outbreaks have highlighted its potential for wider geographic spread. |
|||
Related to Zika. |
|||
{{H2|Etiology and Transmission}} |
|||
Only deaths have been two young healthy women. |
|||
[[Oropouche virus]] is maintained in nature through a cycle involving wild rodents, particularly species of the genus *Oligoryzomys*, which act as reservoir hosts. Human infections occur when sandflies feed on infected rodents and subsequently bite humans. Transmission does not occur directly between humans, but outbreaks can arise in densely populated areas with poor sanitation, where sandfly populations thrive. |
|||
{{H2|Clinical Features}} |
|||
| ⚫ | |||
Infection with [[Oropouche virus]] typically presents with a sudden onset of fever, headache, myalgia, and arthralgia, often accompanied by retro-orbital pain (pain behind the eyes). A characteristic rash may appear on the face, trunk, and extremities. The illness is generally self-limiting, with most patients recovering within one to two weeks. However, severe complications are rare but have been reported in immunocompromised individuals. |
|||
{{H2|Epidemiology and Outbreaks}} |
|||
{{Draft}} |
|||
Historically, [[Oropouche virus]] outbreaks have been sporadic and localized, with significant events recorded in Brazil, Peru, and Colombia. A major outbreak in 2019 in the Amazon region of Brazil affected over 10,000 people, underscoring the virus's potential for large-scale transmission. The virus has also been detected in other parts of South America, including Suriname and Guyana, though its prevalence remains underreported due to limited diagnostic capacity in endemic regions. |
|||
{{Viruses}} |
|||
{{H2|Diagnosis and Treatment}} |
|||
Diagnosis of [[Oropouche virus]] infection relies on serological testing, such as enzyme-linked immunosorbent assays (ELISAs), and molecular methods like reverse transcription-polymerase chain reaction (RT-PCR). No specific antiviral treatment is available, and management is supportive, focusing on hydration, fever control, and rest. Research into vaccine development is ongoing, with several candidate vaccines currently in preclinical trials. |
|||
{{H2|Public Health Implications}} |
|||
The emergence of [[Oropouche virus]] as a re-emerging pathogen has raised concerns among public health officials. Climate change, deforestation, and urbanization are believed to contribute to the expansion of sandfly habitats and increased human exposure. Surveillance programs and vector control measures are critical for mitigating outbreaks. |
|||
{{H2|Research and References}} |
|||
Recent studies have expanded understanding of [[Oropouche virus]]'s genetic diversity and transmission dynamics. A 2024 analysis published in *The Lancet Infectious Diseases* highlighted the role of urbanization in amplifying outbreaks and emphasized the need for improved diagnostic tools. |
|||
| ⚫ | |||
[[Category:Viruses]] |
|||
{{Ollama}} |
|||
{{Pending Human Review}} |
|||
Latest revision as of 22:57, 18 October 2026
Oropouche virus is a zoonotic virus that causes a febrile illness known as Oropouche fever. First identified in 1955 in the Oropouche region of Brazil, the virus belongs to the *Bunyaviridae* family and is primarily transmitted to humans through the bite of infected sandflies (*Psychodidae* family). While initially considered a tropical disease confined to South America, recent outbreaks have highlighted its potential for wider geographic spread.
Etiology and Transmission
Oropouche virus is maintained in nature through a cycle involving wild rodents, particularly species of the genus *Oligoryzomys*, which act as reservoir hosts. Human infections occur when sandflies feed on infected rodents and subsequently bite humans. Transmission does not occur directly between humans, but outbreaks can arise in densely populated areas with poor sanitation, where sandfly populations thrive.
Clinical Features
Infection with Oropouche virus typically presents with a sudden onset of fever, headache, myalgia, and arthralgia, often accompanied by retro-orbital pain (pain behind the eyes). A characteristic rash may appear on the face, trunk, and extremities. The illness is generally self-limiting, with most patients recovering within one to two weeks. However, severe complications are rare but have been reported in immunocompromised individuals.
Epidemiology and Outbreaks
Historically, Oropouche virus outbreaks have been sporadic and localized, with significant events recorded in Brazil, Peru, and Colombia. A major outbreak in 2019 in the Amazon region of Brazil affected over 10,000 people, underscoring the virus's potential for large-scale transmission. The virus has also been detected in other parts of South America, including Suriname and Guyana, though its prevalence remains underreported due to limited diagnostic capacity in endemic regions.
Diagnosis and Treatment
Diagnosis of Oropouche virus infection relies on serological testing, such as enzyme-linked immunosorbent assays (ELISAs), and molecular methods like reverse transcription-polymerase chain reaction (RT-PCR). No specific antiviral treatment is available, and management is supportive, focusing on hydration, fever control, and rest. Research into vaccine development is ongoing, with several candidate vaccines currently in preclinical trials.
Public Health Implications
The emergence of Oropouche virus as a re-emerging pathogen has raised concerns among public health officials. Climate change, deforestation, and urbanization are believed to contribute to the expansion of sandfly habitats and increased human exposure. Surveillance programs and vector control measures are critical for mitigating outbreaks.
Research and References
Recent studies have expanded understanding of Oropouche virus's genetic diversity and transmission dynamics. A 2024 analysis published in *The Lancet Infectious Diseases* highlighted the role of urbanization in amplifying outbreaks and emphasized the need for improved diagnostic tools.
- [The Lancet Infectious Diseases article](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00516-4/fulltext)
This page contains information generated by Ollama. The information was reviewed, and may have been altered, by a human editor before being added to the Featured category. As of July 2026 information generated by AI is not subject to copyright and is thus in the public domain. This page is pending human review.